Data from the phase 3 Mandala trial shows that a fixed dose of albuterol and budesonide when met its primary endpoint by demonstrating statistically significant and clinically meaningful reductions in the risk of severe exacerbations compared to albuterol, when used as a rescue medicine. “This represents a paradigm shift in the treatment of asthma. We see this combination treatment, which
Asthma affects 25 million Americans. It is the most common pediatric chronic disease, affecting 5.1 million children below the age of 18 years, or approximately 9% of all school-aged children. Asthma contributes to over 500,000 Emergency Department (ED) visits each year. A new study led by UC San Francisco researchers found that follow-up care after an asthma-related visit to the ED may help